arrow
K

Kristina Lend

Amsterdam University Medical Center
H指数:7
被引数:263

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patients improve, patterns persist: longitudinal stability of RA joint involvement patterns

患者改善,模式持续:类风湿关节炎关节受累模式的纵向稳定性

2026-10-050
OAAI
Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritis

口服糖皮质激素联合甲氨蝶呤或关节内注射联合三联疗法在早期类风湿关节炎中的flare风险

2026-04-060
OAAI
Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trial

Certolizumab pegol、abatacept、tocilizumab或早期类风湿关节炎的活性常规疗法:NORD-STAR试验的48周患者报告结局

2026-03-230
PRE
Correction: Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort

更正:早期类风湿关节炎的疾病活动度和治疗反应:NORD-STAR队列的一项探索性代谢组学分析

2025-10-030
OA
Acylcarnitine enrichment as a characteristic of rheumatoid arthritis fibroblast-like synoviocyte metabolic fingerprint

酰基肉碱富集作为类风湿关节炎成纤维样滑膜细胞代谢指纹的特征

2025-08-190
OAAI
Association of Soluble Immune Checkpoint Molecules PD1 and 4-1BB With CTLA-4Ig Treatment Response in Early Rheumatoid Arthritis

可溶性免疫检查点分子PD1和4-1BB与早期类风湿关节炎CTLA-4Ig治疗反应的关联

2025-07-070
OAAI
SERUM METABOLOMICS PROFILING IDENTIFIES POTENTIAL BIOMARKERS FOR DISEASE ACTIVITY AND RESPONSETO TREATMENT IN EARLY RHEUMATOID ARTHRITIS- A NORD-STAR SPIN-OFF STUDY

血清代谢组学分析鉴定早期类风湿关节炎疾病活动度及治疗反应的潜在生物标志物——一项Nord-Star衍生研究

2024-06-010
PRE
ULTRASOUND REMISSION RATES AFTER 1 YEAR ARE HIGH IN EARLY RA PATIENTS ON INDUCTION TREATMENT: RESULTS FROM THE RANDOMIZED NORD-STAR TRIAL

早期RA患者在诱导治疗下,1年后的超声缓解率较高:来自随机NORD-STAR试验的结果

2024-06-010
PRE
CIRCULATING ADIPOKINES AND RESPONSE TO TREATMENT IN EARLY RHEUMATOID ARTHRITIS-DATA FROM THE RANDOMIZED NORD-STARTRIAL

循环脂肪因子与早期类风湿关节炎的治疗反应——来自随机NORD-STAR试验的数据

2024-06-010
PRE
Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial
2024-01-182
OAAI
Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomised controlled trial
2022-10-015
OAAI
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial
2020-12-0271
OAAI